Sonja Kriks

Sonja Kriks has worked in the scientific field since 2007 when they began as a Postdoctoral Research Associate at Memorial Sloan Kettering Cancer Center. During their time there, they developed a differentiation protocol for the directed differentiation of pluripotent stem cells into a dopaminergic cell lineage. Her main goal was to obtain an unlimited source of fully specified midbrain dopamine neurons suitable for pre-clinical applications of Parkinson's disease. In 2015, they began working as a Scientist at Neurona Therapeutics, where they have remained in the same role since.

Sonja Kriks obtained a Doctor of Philosophy - PhD in Developmental Neuroscience from The Salk Institute for Biological Studies from 2002 to 2007. Prior to that, they earned a Diplom Biologe (Bachelor of Science) in Biochemistry and Molecular Biology from The University of Göttingen from 1998 to 2002.

Location

San Francisco, United States

Links


Org chart

No direct reports

Teams


Offices


Neurona Therapeutics

1 followers

Neurona Therapeutics is a provider of cell-based medicines dealing with neurological disorders.


Employees

51-200

Links